Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
194 studies found for:    (women OR Female OR woman) | Open Studies | HIV | Studies with Female Participants | Adult, Senior
Show Display Options
Rank Status Study
1 Unknown  Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?
Condition: HIV/AIDS
Interventions: Device: POC CD4;   Other: Programmatic Mentoring
2 Not yet recruiting Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
Condition: HIV Infection
Intervention: Other: Oral HIV Self-Testing
3 Recruiting Zambian Peer-Educators for HIV Self-Testing Study
Condition: HIV Infection
Intervention: Other: Oral HIV Self-Testing
4 Recruiting A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Etravirine;   Drug: Rilpivirine;   Drug: Darunavir/Cobicistat (FDC)
5 Not yet recruiting Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Condition: HIV-1 Infection
Intervention: Drug: Prometrium
6 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
7 Unknown  Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
8 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
9 Not yet recruiting Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts
Conditions: HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Mujer Segura Siempre;   Behavioral: General Health Message Texts
10 Recruiting Improving the Health of South African Women With Traumatic Stress in HIV Care
Conditions: HIV;   Trauma Exposure
Intervention: Behavioral: Improving AIDS Care after Trauma (ImpACT)
11 Recruiting Introducing PrEP Into HIV Combination Prevention - Kenya
Condition: HIV
Intervention: Drug: Truvada
12 Recruiting Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya
Conditions: Depression;   Posttraumatic Stress Disorder;   HIV
Interventions: Behavioral: interpersonal psychotherapy;   Behavioral: treatment as usual
13 Recruiting Implementing a Comprehensive Prevention of Mother-to-Child Transmission of HIV Program for South African Couples
Conditions: HIV;   Pregnancy
Intervention: Behavioral: Protect your family
14 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
15 Recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
16 Unknown  Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
17 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
18 Recruiting Multimedia WORTH With Black Drug-Involved Women on Probation
Conditions: Sexually Transmitted Infections;   HIV;   Gonorrhea;   Trichomonas;   Chlamydia Trachomatis;   Drug Use
Interventions: Behavioral: E-WORTH;   Behavioral: Streamlined HIV Testing
19 Not yet recruiting Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Condition: HIV Infections
Interventions: Drug: Cabotegravir tablets;   Drug: TDF/FTC tablets;   Drug: TDF/FTC placebo tablets;   Drug: CAB placebo tablets;   Drug: CAB LA;   Drug: Placebo for CAB LA
20 Not yet recruiting Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
Conditions: HIV;   Pregnancy
Interventions: Drug: Dolutegravir 50mg od;   Drug: Standard of Care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years